GlobeNewswire

Transaction in Own Shares 09 June, 2026 • • • • • • • • • • • • • • • • Shell plc (the 'Company') announces that on 09 June, 2026 it purchased the following number of Shares for cancellation. Aggregated information on Shares...

NUREMBERG, Germany, June 10, 2026 (GLOBE NEWSWIRE) -- Skyworks Solutions, Inc. (Nasdaq: SWKS), a leading developer, manufacturer and provider of analog and mixed-signal semiconductors and solutions, will showcase its latest power and gate driver...

LEADING EDGE MATERIALS’ WOXNA GRAPHITE TARGETS PREMIUM APPLICATIONS WITH CONFIRMATION OF PURIFICATION ROUTE Flotation testwork produced a high-grade concentrate with 94% carbon purity retaining more than half of all particles as large...

Huw van Steenis to Join as European Economic & Policy Strategist Sarah Jenkins to Join as Head of Government Affairs, Europe LONDON and NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Huw van...

New state-of-the-art facility strengthens Applied’s global manufacturing and R&D capabilities to drive resilience and scalability Tampines Campus sets a new benchmark for sustainable, intelligent semiconductor equipment production ...

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, June 09, 2026 (GLOBE NEWSWIRE) -- High...

BOSTON, June 09, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, announced today the...

CAMBRIDGE, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet...

GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its Board of Directors has appointed Peter Kendall as Interim Chief Executive Officer of the Company, effective...